Kristal, Alan R <br/><br/>
Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.  [electronic resource] 

 -  The Prostate  May 2010 
 - 584-90 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1097-0045 
<br/><br/><label>Standard No.: </label>10.1002/pros.21092  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine Nucleotides--genetics<br/>Aged<br/>Aged, 80 and over<br/>Case-Control Studies<br/>Cytosine Nucleotides--genetics<br/>Genetic Predisposition to Disease--genetics<br/>Guanine Nucleotides--genetics<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Obesity--genetics<br/>Prostatic Hyperplasia--epidemiology<br/>Receptors, Androgen--genetics<br/>Risk Factors<br/>Testosterone--blood<br/>Trinucleotide Repeats--genetics